LL-37 is the only human cathelicidin antimicrobial peptide, playing essential roles in innate immunity and tissue repair.
Research Applications
- Antimicrobial activity
- Wound healing acceleration
- Biofilm disruption
- Immune modulation
- Anti-inflammatory effects
Mechanism
LL-37 disrupts bacterial membranes while also promoting angiogenesis and re-epithelialization in wounds.
Dosing
50-100mcg subcutaneously, daily or every other day.
Research-grade peptides contain only the active ingredient and are NOT equivalent to FDA-approved pharmaceuticals.